Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This thing is on fire! How early did you get in?
Who cares if there was 34%short sales- it went up another 12%!!!!!!!!!!'m
FINRA short sales of LBMH
20131126|LBMH|143554|0|375940|Q
20131126|LBMH|14575|0|22747|N
158,129/458687 or 34.5% of today's volume was short sales!
Go LBMH!!!
Wonderful...
More "non existent shares" in this company as well, eh?
How are they determined if they are "non existent" and if they are "non existent" why do they have to be bought back?
Go ahead let's hear the best theory....
Just the beginning imho, shorts have a bunch of non existent shares to buy back which will take time. Go LBMH!!!
Another nice move up here today.
Making it difficult is nothing new for the SEC, in fact, it is no doubt difficult by design as the size and extent of the shorting on higher eschanges is much less transparent.
I agree that cash dividends make a huge difference to those who are shorting and expect this tool to be utilized much more in the near future by companies that can.
I also agree on the covering. I remember both TASR and SSOL years ago that went from pennies to hundreds of dollars per share with forward splits thrown in for good measure. It took about 6 months for the shorts to cover before they started the downward cycle. This should be fun to watch.
alan ..
just an fyi .. re: daily reg sho
Finra did something that the SEC with all their *resources*
has yet to be able to do .. they collated into one system
daily reg sho for OTC ..
when it comes to a higher exchange (NOT OTC)
one has to to go the dolt's website and pull from various sources
ALL of the daily reg sho data *PROvided* ..
http://www.sec.gov/answers/shortsalevolume.htm
Finra's is just one of many (but it's the easiest to view)
SEC is a national disgrace and they have zero interest in PROtecting retail
my experience with OTC stox that uplist is that the cover is a laddered one
done over time (for example another well shadowed OTC co. saw their stock
go from approx 2.50 at uplist to 15.00 b4 the *cycle* of resets kicked back in)
clearly it comes down to each co.s mgmt and their *respective* awareness level
re: PROs' cycles of $$$$$ always in play and their ability to execute
i like the cash divs in play re: LBMH
it *works* :)
===
4kids
all jmo
This stock value has nothing to do with shorts. This stock is where it's at because of the business success of the Management. I just saw a commercial on a couple of major networks for Liberator's catheter supplies. They are a successful company, with a nationwide customer base, nation wide visibility, with a good advertising/marketing plan. Management has proven past successes. Definitely not a penny stock as like the others. You may have just stumbled upon a real company, with real potential. Only issue is how will medical supplies be handled with obamacare as personal costs are sky rocketing and deductibles are outrageous, which in turn will cause those that need supplies and checkups to not get them as though the insurance may be subsidized, the deductible is not. Then again, medical supplies being asked for by the previous uninsured could increase sales tremendously. Keep a close eye on this one.
This is interesting: 20131122|LBMH|27130|0|53980|N
alan ..
mgmt seems to have the system down pat :)
check fido re: (LBMH dividends)
Dividends:LBMH
LIBERATOR MEDICAL HOLDINGS INC
3.20Up 0.0499 (1.58 %)AS OF 12:38:16PM ET 11/22/2013
Trade Add to Watch List Set Alert Hypothetical Trade Price History down
Dividends Overview
Dividends Detail
Recent Recap
Most Recently
Announced Dividend Frequency Announcement Date Ex-Dividend Date Record Date Pay Date Dividend Type
$0.0300 Quarterly 11/13/2013 12/23/2013 12/26/2013 01/10/2014 Regular
Last report I could locate shows ~ 7,000 short.
Nah, but you're in luck if you're searching for some. 100K available.
Anyone have a handle on the size of the short position?
Check out this Seeking Alpha article on LBMH
http://seekingalpha.com/article/1848511-liberator-medical-supply-the-newest-defensive-safe-and-shareholder-friendly-name-on-the-nyse-mkt
Good rule of thumb - Always take profits after doubling your investments. Congrats!
I agree with all you said. I just couldnt resist 200% profits. I will continue to follow it, may regret selling but profit is profit....
One year chart looks great! Financials look great! Very little debt. Now on NYSE- May one keep at least a small holding.
I owned it at a $1 average and sold today for $3.10, just couldn't resist!
Up listings always do well on first day. Also bought on Monday with 2.27 average. Now the big question is, how long to hold on to this? Might sell tomorrow and buy again on drop.
Looks like the gamble paid off... bought at avg cost of 2.32 on Monday
The filing as posted:
11/20/2013 13:17 LBMH Liberator Medical Holdings, Inc. Common Stock Listed on NYSE Amex (LBMH)
http://www.otcbb.com/asp/dailylist_detail.asp?d=11/19/2013&mkt_ctg=OTCBB
AMEX is now known as NYSE MKT
I should have posted NYSE AMEX as per the filing.
Hmmm, was the recent PR misleading?
LBMH: Finra filing, move to AMEX:
http://www.otcbb.com/asp/dailylist_detail.asp?d=11/19/2013&mkt_ctg=OTCBB
Bought into this yesterday at $2.15. NIce!! Can anyone tell me when management first started talking about up listing? Trying to get a feel how long this was in the process. I own a couple of other OTC stocks and it seems like they have been talking forever about up listing but no action. How hard is it to up list?
Liberator Medical Announces That Its Common Stock Has Been Approved for Listing on the NYSE MKT as of November 20, 2013
STUART, FL -- (Marketwired) -- 11/18/13 -- Liberator Medical Holdings, Inc. (OTCBB: LBMH) today announced that its common stock has been approved for listing on the NYSE MKT. The Company expects its common stock to begin trading on the NYSE MKT on November 20, 2013, trading under the existing symbol "LBMH." The Company's common stock will continue to be quoted on the Over-the-Counter Bulletin Board (the "OTCBB") under the symbol "LBMH" until the shares begin officially trading on the NYSE MKT, after which time the common stock will no longer be quoted on the OTCBB.
Mark Libratore, Liberator Medical's Chief Executive Officer, commented, "We are looking forward to listing on the NYSE MKT. This is a major milestone and marks an important step in our ongoing efforts to maximize shareholder return, and reflects our interest in providing our current and future investor base the most efficient market for trading in the Company's shares. We are confident that our leading market positions and strong customer relationships, combined with the increased visibility of being listed on the NYSE MKT, will help enhance value for all stakeholders. Our focus on profitable growth and extending our position as an industry leader remains a top priority."
"We congratulate Liberator Medical on their listing with NYSE MKT," said Scott Cutler, Executive Vice President, Head of Global Listings, NYSE Euronext. "Our issuer community ranges across a variety of industries and it is always exciting for a healthcare company like Liberator to benefit from our platform and further support their growth."
The Company expects to begin trading on the NYSE MKT on Wednesday, November 20, 2013, using its current ticker symbol "LBHM." Until then, it will continue trading on the OTCBB using "LBMH."
About Liberator Medical Holdings, Inc.
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. Liberator is accredited by the Joint Commission on Accreditation of Healthcare Organizations. Its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, diabetes supplies, catheters, ostomy supplies and mastectomy fashions. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
In this press release and in related comments by our management, our use of the words "expect," "anticipate," "possible," "potential," "target," "believe," "commit," "intend," "continue," "may," "would," "could," "should," "project," "projected," "positioned" or similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. We believe these judgments are reasonable, but these statements are not guarantees of any events or financial results, and our actual results may differ materially due to a variety of important factors. Such risks and uncertainties may include, but are not limited to, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Liberator's most recent annual report on Form 10-K and quarterly reports on Form 10-Q provide information about these and other factors, which we may revise or supplement in future reports filed with the Securities and Exchange Commission.
Contacts:
Individual Investor Relations Contact
WSR Communications
772-219-7525
IR@WSRcommunications.com
http://wsrcommunications.ir.stockpr.com/liberatormedical
Institutional Investor Contact
Lyn Davis
Littlebanc Advisors, LLC
561-948-3005
ld@littlebanc.com
www.littlebanc.com
Source: Liberator Medical Holdings, Inc.
Released November 18, 2013
http://ir.liberatormedical.com/company-news/detail/644
Little oversold here, adding to my position. Too many positives in the pipeline.
Liberator Medical Declares Cash Dividend of $0.03 per Share
This Is the 4th Consecutive Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on December 26, 2013
STUART, FL, Nov 14, 2013 (Marketwired via COMTEX) -- Liberator Medical Holdings, Inc. (otcqb:LBMH) today announced that on November 13, 2013, its Board of Directors approved a cash dividend of $0.03 per common share to its shareholders. This is the fourth cash dividend declared to shareholders in calendar year 2013 and in the Company's history. The dividend will be paid on January 10, 2014, to all shareholders of record as of the close of business on December 26, 2013.
The Company's policy is to pay a sustainable quarterly dividend to its shareholders. The Company's Board of Directors evaluates on a quarterly basis the amount and timing of future dividends based on the Company's operating results, financial condition, capital requirements and general business conditions. The amount and timing of dividends may vary, and the payment of any dividend does not assure that the Company will be able to pay or will declare dividends in the future.
About Liberator Medical Holdings, Inc.
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. An Exemplary Provider(TM) accredited by The Compliance Team, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, diabetes supplies, catheters, ostomy supplies and mastectomy fashions. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
In this press release and in related comments by our management, our use of the words "expect," "anticipate," "possible," "potential," "target," "believe," "commit," "intend," "continue," "may," "would," "could," "should," "project," "projected," "positioned" or similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. We believe these judgments are reasonable, but these statements are not guarantees of any events or financial results, and our actual results may differ materially due to a variety of important factors. Such risks and uncertainties may include, but are not limited to, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Liberator's most recent annual report on Form 10-K and quarterly reports on Form 10-Q provide information about these and other factors, which we may revise or supplement in future reports filed with the Securities and Exchange Commission.
http://www.marketwatch.com/story/liberator-medical-declares-cash-dividend-of-003-per-share-2013-11-14?reflink=MW_news_stmp
Indeed. Of course, the listing will not be tomorrow.
Current SP could be a bargain...
g.p.
HUGE NEWS! Looks like the company is filing for NYSE listing.
http://ir.liberatormedical.com/sec-filings/content/0001078782-13-002147/f8a110813_8a12b.htm
~ $LBMH ~ Daily Par Sar Buy Signal ~ Criteria alert triggered during a recent trading session!
$LBMH has just triggered the "Parabolic SAR Buy Signals" scan criteria at Stockcharts.com
~ http://tinyurl.com/SAR-BUY ~
For a more in Depth study and DD profile, similar to the one contained in this link: ~ http://tinyurl.com/DDexample ~
Click the following link and type ticker or brief message asking me about the DD: ~ http://tinyurl.com/GET-THE-DD ~
What does the scan "Parabolic SAR Buy Signals" mean? Below is an image example and study link.
~ http://stockcharts.com/school/doku.php?id=chart_school:technical_indicators:parabolic_sar ~
To find other similar posts of "LBMH" utilize the links that follow.
Search MACDgyver's "Parabolic SAR Buy Signals" posts: ~ http://investorshub.advfn.com/boards/msgsearchbymember.aspx?searchID=251916&srchyr=2013&SearchStr=ParSarBuyScan ~
Search MACDgyver's posts for symbol "LBMH": ~ http://investorshub.advfn.com/boards/msgsearchbymember.aspx?searchID=251916&srchyr=2013&SearchStr=LBMH ~
Search Ihub for "LBMH" posts: ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=LBMH ~
For more in depth training and information visit Chartschool on the Stockcharts page.
~ http://stockcharts.com/school/doku.php?id=chart_school ~
Also don't forget the Ihub Edu Channel.
~ http://investorshub.advfn.com/boards/education.aspx ~
c
Buying down here in the low 1.80s
Here's the drop, if it plays out like last run looking like it might see a few more red days until it's ready for a bounce. 50 day MA sitting down at 1.80
New 3 year high.
Liberator Medical Declares Cash Dividend of $0.03 per Share
This Is the 3rd Consecutive Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on September 26, 2013
STUART, FL--(Marketwired - August 30, 2013) - Liberator Medical Holdings, Inc. (OTCQB: LBMH) today announced that on August 30, 2013, its Board of Directors approved a cash dividend of $0.03 per common share to its shareholders. This is the third cash dividend paid to shareholders in 2013 and in the Company's history. The dividend will be paid on October 10, 2013, to all shareholders of record as of the close of business on September 26, 2013.
The Company's policy is to pay a sustainable quarterly dividend to its shareholders. The Company's Board of Directors evaluates on a quarterly basis the amount and timing of future dividends based on the Company's operating results, financial condition, capital requirements and general business conditions. The amount and timing of dividends may vary, and the payment of any dividend does not assure that the Company will be able to pay or will declare dividends in the future.
The Company has purchased 264,649 shares on the open market at an average cost of $1.62 per share since the Board of Directors authorized the buyback of up to 1,000,000 shares of common stock on June 13, 2013.
Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link www.LBMH-IR.com
About Liberator Medical Holdings, Inc.
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. An Exemplary Provider(TM) accredited by The Compliance Team, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, diabetes supplies, catheters, ostomy supplies and mastectomy fashions. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
In this press release and in related comments by our management, our use of the words "expect," "anticipate," "possible," "potential," "target," "believe," "commit," "intend," "continue," "may," "would," "could," "should," "project," "projected," "positioned" or similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. We believe these judgments are reasonable, but these statements are not guarantees of any events or financial results, and our actual results may differ materially due to a variety of important factors. Such risks and uncertainties may include, but are not limited to, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Liberator's most recent annual report on Form 10-K and quarterly reports on Form 10-Q provide information about these and other factors, which we may revise or supplement in future reports filed with the Securities and Exchange Commission.
Contact Information
Contacts:
Individual Investor Relations Contact
WSR Communications
772-219-7525
IR@WSRcommunications.com
http://wsrcommunications.ir.stockpr.com/liberatormedical
Institutional Investor Contact
Lyn Davis
Littlebanc Advisors, LLC
561-948-3005
ld@littlebanc.com
www.littlebanc.com
http://www.marketwire.com/press-release/liberator-medical-declares-cash-dividend-of-003-per-share-otcqb-lbmh-1826091.htm
Expecting more record earnings this quarter here, looks like it may be poised to go above 2 this month.
Liberator Medical Reports Revenue of $17.5 Million for Its Third Fiscal Quarter Ended June 30, 2013
STUART, FL --(Marketwired - August 09, 2013) - Liberator Medical Holdings, Inc. (OTCQB: LBMH) today announced the financial results for its fiscal third quarter ended June 30, 2013. Sales for the three months ended June 30, 2013 increased by $2,530,000, or 16.9%, to $17,491,000, compared with sales of $14,961,000 for the three months ended June 30, 2012. For the nine months ended June 30, 2013, sales increased by $7,349,000, or 16.5%, to $51,776,000, compared with sales of $44,427,000 for the nine months ended June 30, 2012.
Income from operations for the three months ended June 30, 2013, increased by $2,189,000, or 187.6%, to $3,356,000, compared with the three months ended June 30, 2012. For the nine months ended June 30, 2013, income from operations increased by $4,888,000, or 158.5%, to $7,972,000, compared with the nine months ended June 30, 2012.
Net income for the three months ended June 30, 2013 was $2,014,000 compared with net income of $676,000 for the three months ended June 31, 2012, representing an increase of 197.9%. Net income for the nine months ended June 30, 2013 was $4,786,000 compared with net income of $1,800,000 for the nine months ended June 30, 2012, representing an increase of 165.9%.
On June 13, 2013, the Company's Board of Directors approved a cash dividend of $0.03 per common share to its shareholders of record on July 8, 2013. The dividend was paid on July 22, 2013, and is the second cash dividend paid this year.
The Company's Board of Directors also approved a 1,000,000 share repurchase program on June 13, 2013. As of August 8, 2013, the Company has repurchased 195,000 shares since the commencement of the share buyback.
Mark Libratore, the Company's President and CEO, commented, "During the third quarter of fiscal year 2013 we generated net income of $2.0 million and increased our cash balance by $3.6 million to $10.6 million at the end of the quarter. As a result of the improvements in our operating margins and cash flows during the first three quarters of fiscal year 2013, we have paid two quarterly dividends, totaling $2.6 million, to our shareholders and initiated a buyback of 1.0 million shares of our common stock. During July 2013, we completed an acquisition of a small medical supply company and are currently evaluating other potential small company acquisitions. We expect to continue to increase our operating margins and cash flows and continue to acquire new customers through our direct-response advertising efforts at our targeted acquisition costs."
Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link www.LBMH-IR.com
About Liberator Medical Holdings, Inc.
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. An Exemplary Provider™ accredited by The Compliance Team, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, personal mobility aids, diabetes supplies, catheters, ostomy supplies and mastectomy fashions. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
In this press release and in related comments by our management, our use of the words "expect," "anticipate," "possible," "potential," "target," "believe," "commit," "intend," "continue," "may," "would," "could," "should," "project," "projected," "positioned" or similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. We believe these judgments are reasonable, but these statements are not guarantees of any events or financial results, and our actual results may differ materially due to a variety of important factors. Such risks and uncertainties may include, but are not limited to, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Liberator's most recent annual report on Form 10-K and quarterly reports on Form 10-Q provide information about these and other factors, which we may revise or supplement in future reports filed with the Securities and Exchange Commission.
Liberator Medical Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
As of June 30, 2013 (unaudited) and September 30, 2012
(In thousands, except dollar per share amounts)
June 30, September 30,
2013 2012
------------- -------------
Assets
Current Assets:
Cash $ 10,610 $ 3,326
Accounts receivable, net of allowance of
$4,984 and $5,044, respectively 8,380 10,365
Inventory, net of allowance for obsolete
inventory of $467 and $310, respectively 1,923 2,627
Deferred taxes, current portion 2,365 2,254
Prepaid and other current assets 346 287
------------- -------------
Total Current Assets 23,624 18,859
Property and equipment, net of accumulated
depreciation of $3,344and $2,888,
respectively 1,155 1,250
Deferred advertising 22,915 22,426
Intangible assets, net of accumulated
amortization of $144 and $91, respectively 232 239
Other assets 99 88
------------- -------------
Total Assets $ 48,025 $ 42,862
============= =============
Liabilities and Stockholders' Equity
Current Liabilities:
Accounts payable $ 4,255 $ 6,537
Accrued liabilities 2,442 1,221
Dividends payable 1,572 -
Other current liabilities 100 92
------------- -------------
Total Current Liabilities 8,369 7,850
Deferred tax liability 7,685 5,421
Credit line facility 2,500 2,500
Other long-term liabilities 64 132
------------- -------------
Total Liabilities 18,618 15,903
------------- -------------
Stockholders' Equity:
Common stock, $.001 par value, 200,000 shares
authorized, 52,490 and 48,232 shares issued,
respectively; 52,401 and 48,143 shares
outstanding at June 30, 2013, and September
30, 2012, respectively 52 48
Additional paid-in capital 34,981 34,707
Accumulated deficit (5,576) (7,746)
Treasury stock, at cost; 89 shares at June 30,
2013, and September 30, 2012 (50) (50)
------------- -------------
Total Stockholders' Equity 29,407 26,959
------------- -------------
Total Liabilities and Stockholders' Equity $ 48,025 $ 42,862
============= =============
See accompanying notes to unaudited condensed consolidated financial statements.
Liberator Medical Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
For the three and nine months ended June 30, 2013 and 2012
(Unaudited)
(in thousands, except per share amounts)
Three Months Ended Nine Months Ended
June 30, June 30,
-------------------- --------------------
2013 2012 2013 2012
--------- --------- --------- ---------
Sales $ 17,491 $ 14,961 $ 51,776 $ 44,427
Cost of Sales 6,598 5,836 19,172 17,526
--------- --------- --------- ---------
Gross Profit 10,893 9,125 32,604 26,901
--------- --------- --------- ---------
Operating Expenses
Payroll, taxes and benefits 3,570 3,526 11,079 10,567
Advertising 2,146 1,956 6,617 5,896
Bad debts 541 1,028 2,986 3,001
Depreciation and amortization 171 206 509 615
General and administrative 1,109 1,242 3,441 3,738
--------- --------- --------- ---------
Total Operating Expenses 7,537 7,958 24,632 23,817
--------- --------- --------- ---------
Income from Operations 3,356 1,167 7,972 3,084
--------- --------- --------- ---------
Other Expense
Interest expense (20) (21) (62) (53)
--------- --------- --------- ---------
Total Other Expense (20) (21) (62) (53)
--------- --------- --------- ---------
Income before Income Taxes 3,336 1,146 7,910 3,031
Provision for Income Taxes 1,322 470 3,124 1,231
--------- --------- --------- ---------
Net Income $ 2,014 $ 676 $ 4,786 $ 1,800
========= ========= ========= =========
Basic earnings per share:
Weighted average shares
outstanding 51,837 48,098 49,387 48,081
Earnings per share $ 0.04 $ 0.01 $ 0.10 $ 0.04
Diluted earnings per share:
Weighted average shares
outstanding 52,393 52,279 52,386 52,273
Earnings per share $ 0.04 $ 0.01 $ 0.09 $ 0.03
Dividends declared per common
share * $ 0.05 - $ 0.05 $ -
* Two quarterly dividends were declared during the three months ended June 30, 2013.
See accompanying notes to unaudited condensed consolidated financial statements.
Liberator Medical Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
For the nine months ended June 30, 2013 and 2012
(Unaudited)
(in thousands)
Nine Months Ended
June 30,
----------------------
2013 2012
---------- ----------
Cash flow from operating activities:
Net Income $ 4,786 $ 1,800
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation and amortization 6,996 6,386
Equity based compensation 63 115
Provision for doubtful accounts and contractual
adjustments 3,214 3,039
Deferred income taxes 2,153 1,208
Reserve for inventory obsolescence 157 98
Changes in operating assets and liabilities:
Accounts receivable (1,230) (5,220)
Deferred advertising (6,975) (9,104)
Inventory 547 344
Other assets (95) (252)
Accounts payable (2,282) (20)
Accrued liabilities 1,234 326
Other liabilities (7) (78)
---------- ----------
Net Cash Flow Provided by (Used in) Operating
Activities 8,561 (1,358)
---------- ----------
Cash flow from investing activities:
Purchase of property and equipment (361) (112)
---------- ----------
Net Cash Flow Used in Investing Activities (361) (112)
---------- ----------
Cash flow from financing activities:
Proceeds from exercise of options and warrants 153 -
Proceeds from employee stock purchase plan 48 56
Proceeds from credit line facility - 1,000
Costs associated with credit line facility (21) (21)
Cash dividends paid (1,044) -
Payments of debt and capital lease obligations (52) (22)
---------- ----------
Net Cash Flow Provided by (Used in) Financing
Activities (916) 1,013
---------- ----------
Net increase (decrease) in cash 7,284 (457)
Cash at beginning of period 3,326 3,016
---------- ----------
Cash at end of period $ 10,610 $ 2,559
========== ==========
Supplemental disclosure of cash flow information:
Cash paid for interest $ 63 $ 51
Cash paid for income taxes $ 104 $ -
Supplemental schedule of non-cash investing and
financing activities:
Capital expenditures funded by capital lease
borrowing $ - $ 120
Cash dividends declared, but not yet paid $ 1,572 $ -
See accompanying notes to unaudited condensed consolidated financial statements
Contacts:
Individual Investor Relations Contact
WSR Communications
772-219-7525
IR@WSRcommunications.com
http://wsrcommunications.ir.stockpr.com/liberatormedical
Institutional Investor Contact
Lyn Davis
Littlebanc Advisors, LLC
561-948-3005
ld@littlebanc.com
www.littlebanc.com
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
403
|
Created
|
06/22/07
|
Type
|
Free
|
Moderators |
Investment Highlights:
Liberator Medical Holdings , Inc.
2979 SE Gran Park Way
Stuart, FL 34997
United States
Phone: 772-287-2414
Fax: 772-286-7881
Website: http://www.liberatormedical.com or http://www.liberatordirect.com/
OTCBB: LBMH.OB
Overview
Liberator Medical Supply, Inc. (“LMS”), a wholly-owned subsidiary of the Company, is a federally licensed, direct-to-consumer, provider of Medicare Part B Benefits focused on providing medical supplies in a retail environment and via the Internet in the United States. LMS distributes a full range of medical products which address the healthcare needs of our customers.
We market our products directly to consumers primarily through targeted media and direct response television advertising. Our customer service representatives are specifically trained to communicate with Medicare-eligible beneficiaries. Our operating platforms enable us to collect and process required documents from physicians and customers, bill and collect amounts due from Medicare and/or other government agencies and/or third party payors and/or customers.
Executive Summary
Our emphasis continues to be on top line sales growth while controlling our costs in order to sustain profitable growth. For the third quarter of fiscal year 2010, our sales increased by 53%, to $10.6 million, compared with the third quarter of fiscal year 2009. For the nine months ended June 30, 2010, our sales increased by 62%, to $29.4 million, compared with the nine months ended June 30, 2009.
We have been able to significantly grow our sales over the last three fiscal years through the downturn in the U.S. economy. Our growth has been driven by our direct response marketing campaign, primarily through television ads at remnant (discounted) rates. Based on information from our media buying agents, we believe that demand for television time slots within the direct response advertising market has increased over the last nine months, creating a more competitive environment within this medium. Although customer acquisition costs remain at acceptable levels, during the third quarter of fiscal year 2010 we increased our spending significantly in alternative media channels and plan to continue those efforts.
Over the last nine months, we have invested heavily in our infrastructure by adding both personnel and facilities, so that we continue to remain capable of supporting a much higher sales volume. We currently have approximately 50% of each of our facilities available for future growth. We have chosen to build our infrastructure ahead of our advertising spend, which helps us achieve compliance on many fronts and maintain the quality of our customer service. Our cost structure continues to remain flexible enough to adapt to changing market conditions. We can pulse our advertising spend and the expansion of our workforce relatively quickly based on the results of our marketing programs. While our sales have increased during the last nine months, we have been able to decrease our general and administrative costs as a percentage of sales.
We believe we are well positioned to continue to grow our sales and improve profitability over the long term.
Management Team:
http://www.liberatormedical.com/investor-relations.aspx
CEO: Mark Libratore
Outstanding Shares: 44.6 Million
Float: 6.96Million
======================================================================================================================================================================================================================================
Revenue Per Quarter
September 30th, 2012 $16,516,000
December 31st, 2012 $17,551,000
March 31st, 2013 $16,734,000
June 30th, 2013 $17,491,000
Annual Revenue
September 30th, 2010 $40,919,000
September 30th, 2011 $52,698,000
September 30th, 2012 $60,943,000
September 30th, 2013 $69,111,000
======================================================================================================================================================================================================================================
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |